Status:
COMPLETED
Safety and Efficacy Study of RTS,S AS02A/AS01B Vaccine to Prevent Malaria
Lead Sponsor:
U.S. Army Medical Research and Development Command
Collaborating Sponsors:
GlaxoSmithKline
Walter Reed Army Institute of Research (WRAIR)
Conditions:
Malaria
Eligibility:
All Genders
18-45 years
Phase:
PHASE1
PHASE2
Brief Summary
This is a double blinded study where 2 test vaccines will be evaluated to see if they protect persons who have never had malaria against malaria infection when bitten by mosquitoes.
Eligibility Criteria
Inclusion
- Be in good general health
- Be able to participate for 4-15 months
Exclusion
- Pregnant or planning pregnancy
- History of malaria or exposure to malaria in past 12 months
- Received an investigational malaria vaccine
- Past history of allergic reaction to previous immunization
- Positive blood tests for HIV and specific types of hepatitis
Key Trial Info
Start Date :
December 1 2003
Trial Type :
INTERVENTIONAL
End Date :
January 1 2006
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT00075049
Start Date
December 1 2003
End Date
January 1 2006
Last Update
August 21 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Walter Reed Army Institute of Research
Silver Spring, Maryland, United States, 20910